Spero Therapeutics

-$0.0244 (-3.13%) As of 4:28 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A.

CEO
Ankit A. Mahadevia
Employees
146
Headquarters
Cambridge, Massachusetts
Founded
2013

SPRO Key Statistics

Market cap
24.85M
Price-Earnings ratio
—
Dividend yield
—
Average volume
636.54K
High today
$0.7977
Low today
$0.7511
Open price
$0.7808
Volume
146.81K
52 Week high
$19.87
52 Week low
$0.7321

SPRO Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure